PLUS1
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 11.81 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Athenex Inc | ATNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.10 | 0.85% | 11.81 | 12.03 | 11.65 | 11.99 | 11.71 | 18:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 11.40 | 13.87 | 2.47 | 17.81% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,656 | 483,582 | $ 11.88 | $ 5,743,720 | 1,091,931 | 8.82 - 21.11 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:01:01 | 2 | $ 12.00 | USD |
Athenex Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 912.83M | 77.29M | $ -117.44M | -1.80 | - | 70.19M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Athenex News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/12/2019 | 16:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/12/2019 | 06:09 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 11/07/2019 | 07:06 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/07/2019 | 07:00 | GlobeNewswire Inc. | Athenex, Inc. Announces Third Quarter 2019 Financial Results |
| 10/30/2019 | 07:00 | GlobeNewswire Inc. | Athenex Announces European Commission Grants Orphan.. |
| 10/28/2019 | 03:30 | GlobeNewswire Inc. | Athenex Announces Progress Update from Partner Almirall on.. |
| 10/24/2019 | 07:00 | GlobeNewswire Inc. | Athenex Provides An Update to Shareholders |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATNX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.62 | 12.15 | 11.10 | 11.64 | 560,173 | 0.19 | 1.64% |
| 1 Month | 10.97 | 12.15 | 8.82 | 10.97 | 1,308,937 | 0.84 | 7.66% |
| 3 Months | 15.58 | 15.87 | 8.82 | 12.02 | 803,043 | -3.77 | -24.2% |
| 6 Months | 14.02 | 21.11 | 8.82 | 14.32 | 729,739 | -2.21 | -15.76% |
| 1 Year | 11.72 | 21.11 | 8.82 | 13.66 | 544,915 | 0.09 | 0.77% |
| 3 Years | 12.00 | 21.11 | 8.82 | 14.87 | 384,321 | -0.19 | -1.58% |
| 5 Years | 12.00 | 21.11 | 8.82 | 14.87 | 384,321 | -0.19 | -1.58% |
Athenex Description
| Athenex Inc is a global biopharmaceutical company. It is dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company's mission is to improve the lives of cancer patients by creating more effective, safer and tolerable treatments. The company has organized its business model into three segments, Oncology Innovation Platform, Commercial Platform and Global Supply Chain Platform with operations in both the U.S. and China. |
